{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T04:30:16Z","timestamp":1679545816722},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:00:00Z","timestamp":1639180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:00:00Z","timestamp":1639180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1038\/s41390-021-01892-x","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T10:02:35Z","timestamp":1639216955000},"page":"918-923","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of hydroxyurea on lymphocyte subsets in children with sickle cell anemia"],"prefix":"10.1038","volume":"93","author":[{"given":"Khalid I.","family":"Elsayh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helal F.","family":"Hetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervat A. M.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa M.","family":"Embaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail L.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safwat M.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab Albadry M.","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Elhoufey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliaa M. A.","family":"Ghandour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa M.","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,11]]},"reference":[{"key":"1892_CR1","doi-asserted-by":"publisher","first-page":"107602961982883","DOI":"10.1177\/1076029619828839","volume":"25","author":"AM Zahran","year":"2019","unstructured":"Zahran, A. M. et al. Circulating microparticles in children with sickle cell anemia in a tertiary center in Upper Egypt. Clin. Appl. Thromb. Hemost. 25, 1076029619828839 (2019).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"1892_CR2","first-page":"10","volume":"7","author":"FM Fahim","year":"2013","unstructured":"Fahim, F. M. et al. Growth parameters and vitamin D status in children with thalassemia major in upper Egypt. Int. J. Hematol. Oncol. Stem Cell Res. 7, 10\u201314 (2013).","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"1892_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-021-01627-y","author":"AM Zahran","year":"2021","unstructured":"Zahran, A. M. et al. Regulatory T-cell phenotypes in children with sickle cell disease. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-021-01627-y (2021).","journal-title":"Pediatr. Res."},{"key":"1892_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2020.04.012","volume":"224","author":"J de Azevedo","year":"2020","unstructured":"de Azevedo, J. & Malmegrim, K. Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives. Immunol. Lett. 224, 1\u201311 (2020).","journal-title":"Immunol. Lett."},{"key":"1892_CR5","doi-asserted-by":"publisher","first-page":"107602961989511","DOI":"10.1177\/1076029619895111","volume":"26","author":"AM Zahran","year":"2020","unstructured":"Zahran, A. M. et al. Effect of Hydroxyurea treatment on the inflammatory markers among children with sickle cell disease. Clin. Appl. Thromb. Hemost. 26, 1076029619895111 (2020).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"1892_CR6","doi-asserted-by":"publisher","first-page":"e584","DOI":"10.1097\/HS9.0000000000000584","volume":"5","author":"G Salinas Cisneros","year":"2021","unstructured":"Salinas Cisneros, G. & Thein, S. L. Research in sickle cell disease: from bedside to bench to bedside. Hemasphere 5, e584 (2021).","journal-title":"Hemasphere"},{"key":"1892_CR7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/bjh.13326","volume":"169","author":"RS Nickel","year":"2015","unstructured":"Nickel, R. S. et al. Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy. Br. J. Haematol. 169, 574\u201383. (2015).","journal-title":"Br. J. Haematol."},{"key":"1892_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/ajh.24438","volume":"91","author":"E Balandya","year":"2016","unstructured":"Balandya, E. et al. Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses. Am. J. Hematol. 91, 938\u2013946 (2016).","journal-title":"Am. J. Hematol."},{"key":"1892_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1056\/NEJMoa1813598","volume":"380","author":"L Tshilolo","year":"2019","unstructured":"Tshilolo, L. et al. Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa. N. Engl. J. Med. 380, 121\u2013131 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1892_CR10","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","volume":"14","author":"PT McGann","year":"2015","unstructured":"McGann, P. T. & Ware, R. E. Hydroxyurea therapy for sickle cell anemia. Expert Opin. Drug Saf. 14, 1749\u20131758 (2015).","journal-title":"Expert Opin. Drug Saf."},{"key":"1892_CR11","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","volume":"377","author":"WC Wang","year":"2011","unstructured":"Wang, W. C. et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 377, 1663\u20131663 (2011).","journal-title":"Lancet"},{"key":"1892_CR12","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1158\/1055-9965.1452.13.9","volume":"13","author":"P Duramad","year":"2004","unstructured":"Duramad, P. et al. Flow cytometric detection of intracellular TH1\/TH2 cytokines using whole blood: validation of immunologic biomarker for use in epidemiologic studies. Cancer Epidemiol. Biomark. Prev. 13, 1452\u20131458 (2004).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1892_CR13","first-page":"e13453","volume":"13","author":"F Alzahrani","year":"2021","unstructured":"Alzahrani, F. et al. Hydroxyurea use among children with sickle cell disease at King Abdulaziz University Hospital in Jeddah city. Cureus 13, e13453 (2021).","journal-title":"Cureus"},{"key":"1892_CR14","doi-asserted-by":"publisher","unstructured":"Colombatti, R. et al. Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: results of a National Multicenter survey. Pediatr. Blood Cancer https:\/\/doi.org\/10.1002\/pbc.26774 (2018).","DOI":"10.1002\/pbc.26774"},{"key":"1892_CR15","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1182\/blood-2009-05-221333","volume":"115","author":"E Voskaridou","year":"2010","unstructured":"Voskaridou, E. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 115, 2354\u20132363 (2010).","journal-title":"Blood"},{"key":"1892_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ajh.23629","volume":"89","author":"B Vingert","year":"2014","unstructured":"Vingert, B. et al. Partial dysfunction of Treg activation in sickle cell disease. Am. J. Hematol. 89, 261\u2013266 (2014).","journal-title":"Am. J. Hematol."},{"key":"1892_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-5-396","volume":"5","author":"A Akinbami","year":"2012","unstructured":"Akinbami, A. et al. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Res. Notes 5, 396 (2012).","journal-title":"BMC Res. Notes"},{"key":"1892_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000362148","volume":"133","author":"D Brunetta","year":"2015","unstructured":"Brunetta, D. et al. Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemia. Acta Haematol. 133, 287\u2013294 (2015).","journal-title":"Acta Haematol."},{"key":"1892_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","volume":"332","author":"S Charache","year":"1995","unstructured":"Charache, S. et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 332, 1317\u20131322 (1995).","journal-title":"N. Engl. J. Med."},{"key":"1892_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1182\/blood-2014-12-616250","volume":"126","author":"CB Almeida","year":"2015","unstructured":"Almeida, C. B. et al. Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea. Blood 126, 711\u2013720 (2015).","journal-title":"Blood"},{"key":"1892_CR21","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1182\/blood-2012-02-409524","volume":"120","author":"CB Almeida","year":"2012","unstructured":"Almeida, C. B. et al. Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice. Blood 120, 2879\u20132888 (2012).","journal-title":"Blood"},{"key":"1892_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3324\/haematol.12119","volume":"93","author":"AA Canalli","year":"2008","unstructured":"Canalli, A. A. et al. Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation. Haematologica 93, 605\u2013609 (2008).","journal-title":"Haematologica"},{"key":"1892_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/cc11157","volume":"16","author":"DS Heffernan","year":"2012","unstructured":"Heffernan, D. S. et al. Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit. Care 16, R12 (2012).","journal-title":"Crit. Care"},{"key":"1892_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1542\/peds.2014-0571","volume":"134","author":"HM Lederman","year":"2014","unstructured":"Lederman, H. M. et al. Immunologic effects of hydroxyurea in sickle cell anemia. Pediatrics 134, 686\u2013695 (2014).","journal-title":"Pediatrics"},{"key":"1892_CR25","doi-asserted-by":"publisher","first-page":"25561","DOI":"10.1007\/s00277-006-0246-6","volume":"86","author":"N Conran","year":"2007","unstructured":"Conran, N. et al. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease. Ann. Hematol. 86, 25561 (2007).","journal-title":"Ann. Hematol."},{"key":"1892_CR26","doi-asserted-by":"crossref","unstructured":"Wallace, K. L. et al. NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood 114, 667\u2013676 (2009).","DOI":"10.1182\/blood-2009-02-205492"},{"key":"1892_CR27","doi-asserted-by":"publisher","first-page":"17478942020","DOI":"10.1155\/2020\/1747894","volume":"2020","author":"PB Daltro","year":"2020","unstructured":"Daltro, P. B. et al. CD4+ T cell profile and activation response in sickle cell disease patients with osteonecrosis. Mediat. Inflamm. 2020, 17478942020 (2020).","journal-title":"Mediat. Inflamm."},{"key":"1892_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000041049","volume":"103","author":"R Raghupathy","year":"2000","unstructured":"Raghupathy, R. et al. Th1 and Th2 cytokine profiles in sickle cell disease. Acta Haematol. 103, 197\u2013202 (2000).","journal-title":"Acta Haematol."},{"key":"1892_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/ejh.12361","volume":"93","author":"KA Nottage","year":"2014","unstructured":"Nottage, K. A. et al. Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyurea. Eur. J. Haematol. 93, 377\u2013383 (2014).","journal-title":"Eur. J. Haematol."},{"key":"1892_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1378\/chest.10-1243","volume":"139","author":"JJ Field","year":"2011","unstructured":"Field, J. J. et al. Airway hyperresponsiveness in children with sickle cell anemia. Chest 139, 563\u2013568 (2011).","journal-title":"Chest"},{"key":"1892_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1172\/JCI77250","volume":"126","author":"MS Eiymo Mwa Mpollo","year":"2016","unstructured":"Eiymo Mwa Mpollo, M. S. et al. Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13. J. Clin. Investig. 126, 571\u2013584 (2016).","journal-title":"J. Clin. Investig."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01892-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01892-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01892-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T17:03:41Z","timestamp":1679504621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01892-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,11]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1892"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01892-x","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,11]]},"assertion":[{"value":"22 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All protocols and investigations of our study followed the regulations of the research ethics committee of Assiut University. All caregivers of all participants have given their informed written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}